HypeCheck
← All Ingredients Anti Inflammatory

Last verified: today

Curcumin

Also known as: turmeric extract, Curcuma longa, diferuloylmethane, nanocurcumin

Evidence under review. — Not yet rated

Polyphenol from turmeric. Best evidence for antioxidant effects; anti-inflammatory benefits are promising but inconsistent.

  • What it does

    Curcumin is the active polyphenolic compound extracted from turmeric root (Curcuma longa). Clinical trials show it can meaningfully reduce oxidative stress markers — increasing total antioxidant...

  • Evidence quality

    Evidence base hasn't been formally rated yet. See research below.

  • Clinical dose

    500-2000 mg daily (standard); lower doses used in nanocurcumin formulations

What the Science Says

Curcumin is the active polyphenolic compound extracted from turmeric root (Curcuma longa). Clinical trials show it can meaningfully reduce oxidative stress markers — increasing total antioxidant capacity and lowering markers of lipid peroxidation — particularly in people with type 2 diabetes. Preliminary evidence also suggests it may reduce inflammatory markers like neutrophil-to-lymphocyte ratio in metabolic disease, and early pilot data hints at mood benefits in bipolar depression, though larger controlled trials are still needed.

What It Doesn't Do

Won't reliably lower blood sugar or HbA1c on its own — meta-analysis of 7 RCTs found no significant effect on fasting glucose or HbA1c. Doesn't meaningfully improve cholesterol or triglycerides based on current clinical data. Not a proven cancer treatment in humans — lab and animal findings haven't translated to clinical benefit. The glioblastoma combo trial showed no survival advantage. Not a standalone antidepressant — the bipolar depression pilot had only 6 participants with no control group.

Evidence-Based Benefits

Significantly increases antioxidant capacity and reduces oxidative stress markers in people with type 2 diabetes.

Moderate Evidence

Effective at: Nanocurcumin formulations used across 7 RCTs

Supporting studies (click to view on PubMed):

Reduces inflammatory markers including neutrophil-to-lymphocyte ratio in obese adults with type 2 diabetes.

Weak Evidence

Effective at: Not specified in abstract

Supporting studies (click to view on PubMed):

May reduce depression severity in youth with bipolar disorder, possibly by lowering oxidative stress.

Weak Evidence

Effective at: 500–2000 mg daily over 8 weeks

Supporting studies (click to view on PubMed):

Part of a multi-herb formula that improved liver enzyme levels (ALT, AST, ALP, GGT) in healthy adults over 6 months.

Weak Evidence

Effective at: 60 mL twice daily of multi-ingredient liquid formula

Supporting studies (click to view on PubMed):

Absorption & Bioavailability

Poor — standard curcumin is poorly absorbed from the gut. Nanocurcumin and other enhanced formulations (liposomal, piperine-combined) were developed specifically to address this. Studies using nanocurcumin still show inconsistent clinical results despite improved absorption.

Red Flags to Watch For

  • Poor bioavailability of standard curcumin means many cheap supplements may deliver little active compound — look for enhanced-absorption formulations
  • Most exciting cancer and neuroprotection claims come from lab or animal studies, not human trials
  • Multi-ingredient products (like the glioblastoma trial or liver formula) make it impossible to attribute effects to curcumin alone
  • High doses (2000 mg+) used in some trials — long-term safety at these levels is not well established from the provided studies
  • Supplement market is saturated with 1000+ registered products; quality and curcumin content vary widely

Products Containing Curcumin

See how Curcumin is used in these analyzed products:

Research Sources

  • PubMed
  • NIH DSLD

This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25